Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: Massive parallel sequencing in individuals with multiple primary tumours reveals the benefit of re-analysis

Original Submission
20 Jun 2021 Submitted Original manuscript
5 Jul 2021 Reviewed Reviewer Report - Marcin Lener
27 Aug 2021 Reviewed Reviewer Report - James Whitworth
22 Sep 2021 Author responded Author comments - Karin Margareta Wallander
Resubmission - Version 2
22 Sep 2021 Submitted Manuscript version 2
27 Sep 2021 Reviewed Reviewer Report - Marcin Lener
11 Oct 2021 Reviewed Reviewer Report - James Whitworth
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
12 Oct 2021 Editorially accepted
28 Oct 2021 Article published 10.1186/s13053-021-00203-z

You can find further information about peer review here.

Back to article page

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287